Metraipolis › archive › dc_46fd192da0ef

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial… — Europe PMC PMID:41553085

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41553085
DOI: 10.1161/jaha.125.044113
License (as archived): solo-consultazione
Archived: 2026-11-06T17:12:10.976Z
SHA-256 of the archived text: f1e2f7e144726f109ef52eba615741e3467464dbb353a7237b3b1cc740739f7a
Stable URL of this page: https://metraipolis.com/documento/dc_46fd192da0ef

How to cite

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial… — Europe PMC PMID:41553085 — Europe PMC (en), https://europepmc.org/article/MED/41553085 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_46fd192da0ef (Metraipolis archive dc_46fd192da0ef, sha256 f1e2f7e144726f109ef52eba615741e3467464dbb353a7237b3b1cc740739f7a)

BibTeX

@misc{dc46fd192da0ef,
  title = {Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial… — Europe PMC PMID:41553085},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41553085},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_46fd192da0ef; sha256 f1e2f7e144726f109ef52eba615741e3467464dbb353a7237b3b1cc740739f7a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41553085. Agents can read the archived copy with the MCP tool read_document.